Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05286879Not ApplicableCompleted
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
Infectious DiseaseOpioid Use DisorderRisk Reduction Behavior+3 more
PrincipalinvestigatorStart date: 2022-03-31
NCT01077310Not ApplicableCompleted
Alcohol Pharmacotherapy for HIV+ Prisoners
AIDSAlcohol DependenceHazardous Drinking+2 more
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Frederick L Altice, MD

Yale University

Very Similar
8 trials

Shared therapeutic areas:

HIVOpioid Use DisorderSubstance Abuse+4 more

Worked with same sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Drug Abuse (NIDA)+1 more
Collaborated on 1 trial
Similarity Score74%

Frederick L Altice

Yale University

Moderately Similar
1 trials

Shared therapeutic areas:

Acquired Immunodeficiency SyndromeDrug DependenceHIV+1 more

Worked with same sponsors:

Baystate Medical CenterNational Institute on Drug Abuse (NIDA)+1 more
Collaborated on 1 trial
Similarity Score44%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

Opioid Use DisorderOpioid-Related DisordersSubstance Use
Similarity Score7%

Anne H Berman, PhD

Karolinska Institutet

Related
14 trials

Shared therapeutic areas:

AlcoholismProblem DrinkingRisk Reduction Behavior
Similarity Score7%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

HIVCommunicable Diseases
Similarity Score5%

Jamie Ostroff, PhD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Acquired Immunodeficiency SyndromeHIV
Similarity Score5%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score5%

Harsha Thirumurthy, PhD

University of Pennsylvania

Related
11 trials

Shared therapeutic areas:

HIVAcquired Immunodeficiency Syndrome
Similarity Score5%

Seetha Shankaran, MD

Wayne State University

Related
49 trials

Shared therapeutic areas:

Substance Abuse

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score2%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Substance Abuse

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05286879Not ApplicablePrincipalInvestigator

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

Infectious DiseaseOpioid Use DisorderRisk Reduction Behavior+3 more
Completed
NCT01077310Not ApplicablePrincipalInvestigator

Alcohol Pharmacotherapy for HIV+ Prisoners

AIDSAlcohol DependenceHazardous Drinking+2 more
Completed
NCT01246401Phase 1/2PrincipalInvestigator

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

AIDSDrug DependenceHIV+1 more
Completed

All 3 trials loaded